Objective The objective of this works was to assess the global prevalence of multidrug-
resistance among A. baumannii causing hospital-acquired (HAP) and ventilator-associated …

Background and objectives: High mortality and healthcare costs area associated with
ventilator-associated pneumonia (VAP) due to Acinetobacter baumannii (A. baumannii). The …

Ventilator-associated pneumonia (VAP) caused by Acinetobacter baumannii remains a
significant cause of morbidity and mortality. Increasing antimicrobial resistance influences …

Background Ventilator-associated pneumonia (VAP) caused by drug-resistant Acinetobacter
baumannii is associated with high mortality in critically ill patients. We identified the …

Background Acinetobacter baumannii (AB) is critical for healthcare-associated infections
(HAI) with significant regional differences in the resistance rate, but its risk factors and …

INTRODUCTION: The increase in the prevalence of multidrug-resistant Acinetobacter
baumannii infections in hospital settings has rapidly emerged worldwide as a serious health …

Objectives To investigate the molecular epidemiology, antimicrobial susceptibility and
carbapenem resistance determinants of Acinetobacter baumannii isolates from respiratory …

Acinetobacter baumannii is characterized by a rapid development of resistance to the
commonly used antimicrobial agents. We investigated the risk factors, clinical features, and …

Background Acinetobacter baumannii has emerged as a major cause of nosocomial
outbreaks. It is particularly associated with nosocomial pneumonia and bloodstream …

Objective: To evaluate therapeutic efficacy of different combined antimicrobial treatments
against Acinetobacter baumannii ventilator-associated pneumonia (VAP). Methods: Clinical …